These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 11251014)

  • 21. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
    Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
    N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.
    Bacci G; Ferrari S; Bertoni F; Rimondini S; Longhi A; Bacchini P; Forni C; Manfrini M; Donati D; Picci P
    J Clin Oncol; 2000 Jan; 18(1):4-11. PubMed ID: 10623687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81.
    Sauer R; Jürgens H; Burgers JM; Dunst J; Hawlicek R; Michaelis J
    Radiother Oncol; 1987 Oct; 10(2):101-10. PubMed ID: 3423301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
    J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
    Paulino AC; Nguyen TX; Mai WY; Teh BS; Wen BC
    Pediatr Blood Cancer; 2007 Aug; 49(2):145-8. PubMed ID: 16732580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.
    Wexler LH; DeLaney TF; Tsokos M; Avila N; Steinberg SM; Weaver-McClure L; Jacobson J; Jarosinski P; Hijazi YM; Balis FM; Horowitz ME
    Cancer; 1996 Aug; 78(4):901-11. PubMed ID: 8756388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The Cooperative Ewing Sarcoma Study CESS 81 of the German Pediatric Oncology Society--analysis after 4 years].
    Jürgens H; Göbel V; Michaelis J; Ramach W; Ritter J; Sauer R; Treuner J; Voûte PA; Winkler K; Göbel U
    Klin Padiatr; 1985; 197(3):225-32. PubMed ID: 3892151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
    Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
    J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
    Krasin MJ; Rodriguez-Galindo C; Billups CA; Davidoff AM; Neel MD; Merchant TE; Kun LE
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):830-8. PubMed ID: 15465200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation therapy as local treatment in Ewing's sarcoma. Results of the Cooperative Ewing's Sarcoma Studies CESS 81 and CESS 86.
    Dunst J; Sauer R; Burgers JM; Hawliczek R; Kürten R; Winkelmann W; Salzer-Kuntschik M; Müschenich M; Jürgens H
    Cancer; 1991 Jun; 67(11):2818-25. PubMed ID: 2025847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.
    Ataergin S; Ozet A; Solchaga L; Turan M; Beyzadeoglu M; Oysul K; Arpaci F; Komurcu S; Surenkok S; Ozturk M
    Med Oncol; 2009; 26(3):276-86. PubMed ID: 18989798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy.
    Delepine N; Delepine G; Cornille H; Voisin MC; Brun B; Desbois JC
    J Chemother; 1997 Oct; 9(5):352-63. PubMed ID: 9373791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
    Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G
    J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.
    Nilbert M; Saeter G; Elomaa I; Monge OR; Wiebe T; Alvegård TA
    Acta Oncol; 1998; 37(4):375-8. PubMed ID: 9743460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
    Krasin MJ; Davidoff AM; Rodriguez-Galindo C; Billups CA; Fuller CE; Neel MD; Merchant TE
    Cancer; 2005 Jul; 104(2):367-73. PubMed ID: 15948159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ewing's sarcoma: experience with 12 cases.
    Zülfikar B; Gedikoğlu G
    J Chemother; 1992 Feb; 4(1):50-5. PubMed ID: 1403071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
    Raciborska A; Bilska K; Drabko K; Chaber R; Sobol G; Pogorzała M; Wyrobek E; Połczyńska K; Rogowska E; Rodriguez-Galindo C; Wożniak W
    Pediatr Blood Cancer; 2014 Dec; 61(12):2170-4. PubMed ID: 25163763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive factors of histological response to primary chemotherapy in Ewing's sarcoma.
    Bacci G; Picci P; Mercuri M; Ferrari S; Longhi A; Cesari M; Rosito P; Mancini AF; Barbieri E; Baldini N
    Acta Oncol; 1998; 37(7-8):671-6. PubMed ID: 10050985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II.
    Burgert EO; Nesbit ME; Garnsey LA; Gehan EA; Herrmann J; Vietti TJ; Cangir A; Tefft M; Evans R; Thomas P
    J Clin Oncol; 1990 Sep; 8(9):1514-24. PubMed ID: 2099751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party.
    Craft AW; Cotterill SJ; Bullimore JA; Pearson D
    Eur J Cancer; 1997 Jun; 33(7):1061-9. PubMed ID: 9376188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.